Mass High Tech Directory

SEMPRUS BIOSCIENCES CORP

Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!

About:

Semprus BioSciences is a VC-backed MIT spinout dedicated to reducing healthcare complications associated with medical devices and improving patient outcomes

Headlines from Mass High Tech about SEMPRUS BIOSCIENCES CORP
Print this Listing

Product Information

Industry Classification Medical Devices
Primary Business Focus Biotechnology - Non-Pharmaceutical
Other Business Offering Other Medical, Materials, Medical Device Contract Manufacturers

Details

Year Established 2006
Ownership Type Private
Venture Funding Subscriber access only
No. of Employees at this location Subscriber access only
Total Number Employees Subscriber access only
Anticipated Workforce Changes Subscriber access only
Foreign Distribution Subscriber access only

Contacts

David Lucchino CEO
Christopher Loose CTO
Laurence Roth VP Product Dev't
Gregory Haas Product Strategy/Regulatory

* Downloads will not contain Personnel E-mail addresses

Search the Directory

(searches company name, description and industry categories)

Company Overview

Focus Biotechnology - Non-Pharmaceutical
Location Cambridge, MA
Size Subscriber access only
Website http://www.semprusbio.com
Revenue Subscriber access only

Contact Information

Address One Kendall Sq
Building 1400W, 1st floor
Cambridge, MA, 02139
Phone 617-577-7755
Fax 617-577-7756
Email Subscriber access only
Website www.semprusbio.com

2012 New England Technology Directory Advertisers

New England Tech Directory | Browse | Subscribe | Advertise | Networking | About Us | Search | RSS Feeds | | Directory License | Update User Info | Directory Privacy Policy | Logout

© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.